Indaptus Therapeutics Inc Earnings Estimates

INDPNASDAQ
$3.71
-0.065-1.72%
At close: Jun 23, 5:00 PM EST
$3.59
-0.12-3.23%
After Hours: 9:02 AM EST

Indaptus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:INDP

Indaptus Therapeutics (INDP) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-1.57 and quarterly revenue of N/A.

In the most recent quarter (Q1), Indaptus Therapeutics reported EPS of $-0.23, beating estimates of $-1.87 by 0.88%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Indaptus Therapeutics has averaged an EPS surprise of 0.51% and a revenue surprise of 0.00%.

Earnings Date
Aug 12
EPS Estimate
$-1.570
Quarterly Revenue Estimate
Annual Revenue
(as of Mar 31)

Indaptus Therapeutics Earnings History

Analyze the earnings history of Indaptus Therapeutics using advanced sorting and filters.

Loading calendar...

Indaptus Therapeutics (INDP) Earnings Per Share

The chart below shows Indaptus Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Indaptus Therapeutics (INDP) Revenue

The chart below shows Indaptus Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

Q

When is Indaptus Therapeutics (NASDAQ:INDP) reporting earnings?

A

Indaptus Therapeutics (INDP) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.

Q

What were the latest earnings per share (EPS) for Indaptus Therapeutics (NASDAQ:INDP)?

A

The Actual EPS was $-0.23, which beat the estimate of $-1.87.

Q

What were Indaptus Therapeutics’s (NASDAQ:INDP) revenues?

A

The Actual Revenue was $0.00, which hit the estimate of $0.00.